MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Avadel Pharmaceuticals plc ROA Ratio 2011-2026 | AVDL
Annual ROA Ratio Avadel Pharmaceuticals plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -29.73 | -97.32 | -103.52 | -31.27 | 2.26 | -21.94 | -50.08 | 26.96 | -16.81 | 18.91 | -48.74 | -36.92 | -2.75 | -12.64 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.96 | -103.52 | -28.83 |
Quarterly ROA Ratio Avadel Pharmaceuticals plc
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.59 | -1.08 | -15.02 | -26.72 | -44.58 | -60.78 | -84.06 | -71.79 | -85.61 | -81.58 | -89.69 | -65.94 | -74.27 | -68.78 | -35.54 | -19.85 | -23.61 | -19.03 | -2.19 | 5.87 | 0.02 | -2.08 | -17.67 | -20.13 | -28.42 | -30.85 | -26.98 | -16.52 | -7.96 | 8.88 | 22.11 | 30.21 | 22.07 | 5.36 | -14.19 | -18.74 | -31.8 | -36.7 | -36.41 | -15.47 | -21.58 | -14.64 | -18.87 | -32.84 | -38.3 | -37.66 | -53.34 | -33.21 | -33.21 | -32.17 | -8.85 | -8.84 | -4.42 | -4.42 | 0.01 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 30.21 | -89.69 | -25.84 |
ROA Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cumberland Pharmaceuticals
CPIX
|
-2.52 | $ 4.68 | 9.09 % | $ 65.8 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-48.08 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-61.13 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-242.23 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-17.34 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-141.05 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-13.11 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-3.8 | $ 2.54 | -1.17 % | $ 1.31 B |  Canada |
 |
Athenex
ATNX
|
-50.69 | - | -23.39 % | $ 1.76 M | USA |
 |
Catalent
CTLT
|
-10.69 | - | - | $ 11.5 B | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-34.9 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-8.75 | - | 2.45 % | $ 38.1 M | Canada |
 |
Organogenesis Holdings
ORGO
|
6.18 | $ 2.37 | -6.32 % | $ 300 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
8.78 | - | -39.89 % | $ 27.7 M | USA |
 |
Pacira BioSciences
PCRX
|
-6.41 | $ 23.15 | -2.07 % | $ 1.07 B | USA |
 |
Endo International plc
ENDP
|
-47.69 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-110.24 | - | - | $ 36.6 M | USA |
 |
Bausch Health Companies
BHC
|
-2.16 | $ 5.75 | 0.35 % | $ 2.1 B | Canada |
 |
Canopy Growth Corporation
CGC
|
-65.18 | $ 1.11 | -1.77 % | $ 119 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-25.25 | $ 1.2 | 1.69 % | $ 1.49 M | USA |
 |
Harrow Health
HROW
|
-1.29 | $ 38.23 | -2.1 % | $ 1.41 B | USA |
 |
Solid Biosciences
SLDB
|
-74.97 | $ 7.27 | 2.83 % | $ 636 M | USA |
 |
Aurora Cannabis
ACB
|
-26.69 | $ 3.41 | -0.58 % | $ 86.3 M | Canada |
 |
Tilray
TLRY
|
-33.73 | $ 5.56 | -1.77 % | $ 3.44 B | Canada |
 |
Jupiter Wellness
JUPW
|
-166.41 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-47.81 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-11.14 | $ 1.36 | -1.45 % | $ 130 M | Canada |
 |
Evolus
EOLS
|
-22.86 | $ 6.36 | -0.47 % | $ 410 M | USA |
 |
Sundial Growers
SNDL
|
-16.12 | $ 1.44 | -1.03 % | $ 3.37 M | Canada |
 |
Veru
VERU
|
-62.57 | $ 2.24 | -1.75 % | $ 302 M | USA |
 |
Emergent BioSolutions
EBS
|
-41.71 | $ 9.5 | 4.05 % | $ 486 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-31.31 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
-1.44 | $ 0.84 | -3.45 % | $ 3.62 M | USA |
 |
ProPhase Labs
PRPH
|
21.06 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-38.66 | - | - | $ 1.42 B | USA |
 |
Assertio Holdings
ASRT
|
-11.38 | $ 22.5 | 0.58 % | $ 144 M | USA |
 |
PetIQ
PETQ
|
0.25 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-61.05 | $ 7.32 | -1.48 % | $ 289 M | USA |
 |
Recro Pharma
REPH
|
-8.65 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-32.94 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-14.58 | $ 0.92 | -4.35 % | $ 45.9 M | USA |
 |
PLx Pharma
PLXP
|
-60.18 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
-9.45 | $ 17.17 | -1.27 % | $ 20 B | USA |
 |
Zomedica Corp.
ZOM
|
-64.44 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-63.1 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-9.3 | $ 0.83 | 6.76 % | $ 29.9 M | USA |
 |
Tricida
TCDA
|
-104.78 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-10.28 | $ 0.53 | 1.26 % | $ 2.27 M |  China |
 |
TherapeuticsMD
TXMD
|
-1.51 | $ 1.98 | -1.49 % | $ 22.9 M | USA |